The goal is to develop a comprehensive risk models for FN which can be used as a guide whether or not to incorporate primary G-CSF prophylaxis for each individual patient.26,27 Some predictive models for neutropenia in the first cycle have already been proposed. The gene discussed is CSF3; the disease is Decreased total neutrophil count.